American Academy of Ophthalmology 2020 – Virtual

World Orphan Drug Congress Europe 2020 – Live Digital

4th Annual Gene Therapy for Rare Disorders Europe – Virtual

EURETINA 2020 – Virtual

Ophthalmology Futures Retina – Virtual Forum

GenSight Biologics Announces Publication of Meta-Analysis Confirming that Spontaneous Recovery in LHON is rare in the Journal of Neuro-Ophthalmology

GenSight Biologics reports new analysis demonstrating statistically significant and clinically meaningful difference between visual outcomes in LUMEVOQ®-treated patients and natural history of Leber Hereditary Optic Neuropathy (LHON)

UMDF Power Surge 2020 – online event

2020 Annual Scientific Meeting ASRS – Virtual format

GenSight Biologics reports final REALITY natural history study results confirming poor spontaneous recovery for LHON patients with ND4 mutation